519 672 2121
Close mobile menu

Canada Newswire reports on Siskinds class action class action relating to the drug Neurontin®.To read full story, please visit http://www.newswire.ca/en/story/903975/canada-wide-neurontin-class-action-notice-of-certification.

News & Views

Blog

The more you understand, the easier it is to manage well.

View Blog

Missed or delayed stroke diagnosis: legal options and why early treatment matters

What is a missed or delayed stroke diagnosis? A missed or delayed stroke diagnosis can have …

New consumer safeguards under British Columbia’s Business Practices and Consumer Protection Act

On March 31, 2025, British Columbia’s Bill 4 received Royal Assent, introducing several chan…